DE69212884D1 - Verfahren zum Herstellen von Simvastatin - Google Patents

Verfahren zum Herstellen von Simvastatin

Info

Publication number
DE69212884D1
DE69212884D1 DE69212884T DE69212884T DE69212884D1 DE 69212884 D1 DE69212884 D1 DE 69212884D1 DE 69212884 T DE69212884 T DE 69212884T DE 69212884 T DE69212884 T DE 69212884T DE 69212884 D1 DE69212884 D1 DE 69212884D1
Authority
DE
Germany
Prior art keywords
simvastatin
making simvastatin
making
lactone
formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69212884T
Other languages
English (en)
Other versions
DE69212884T2 (de
Inventor
Rebecca L Dabora
Gregory L Tewalt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24787670&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69212884(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE69212884D1 publication Critical patent/DE69212884D1/de
Publication of DE69212884T2 publication Critical patent/DE69212884T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69212884T 1991-05-01 1992-04-30 Verfahren zum Herstellen von Simvastatin Expired - Fee Related DE69212884T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/694,164 US5159104A (en) 1991-05-01 1991-05-01 Process to simvastatin ester

Publications (2)

Publication Number Publication Date
DE69212884D1 true DE69212884D1 (de) 1996-09-26
DE69212884T2 DE69212884T2 (de) 1997-02-27

Family

ID=24787670

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69212884T Expired - Fee Related DE69212884T2 (de) 1991-05-01 1992-04-30 Verfahren zum Herstellen von Simvastatin

Country Status (10)

Country Link
US (1) US5159104A (de)
EP (1) EP0511867B1 (de)
JP (1) JPH0764837B2 (de)
AT (1) ATE141584T1 (de)
CA (1) CA2067722A1 (de)
DE (1) DE69212884T2 (de)
DK (1) DK0511867T3 (de)
ES (1) ES2090507T3 (de)
GR (1) GR3021527T3 (de)
IE (1) IE73439B1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0726940A4 (de) 1993-11-02 2001-05-23 Merck & Co Inc Die fuer triolpolyketid - synthase kodierende dna
EP0784605B1 (de) * 1995-08-03 2000-02-16 Dsm N.V. Selektives verfahren zur deacylierung von acylverbindungen
US5763653A (en) * 1997-03-13 1998-06-09 Ranbaxy Laboratories, Ltd. Key intermediates in the manufacture of simvastatin
CA2185961A1 (en) * 1996-09-19 1998-03-20 K.S. Keshava Murthy Process for producing simvastatin
US5763646A (en) * 1997-03-13 1998-06-09 Ranbaxy Laboratories, Ltd. Process for manufacturing simvastatin from lovastatin or mevinolinic acid
ZA9810764B (en) * 1998-04-22 1999-08-13 Ranbaxy Lab Ltd An improved process of lactonization in the preparation of statins.
CA2240983A1 (en) 1998-06-18 1999-12-18 Yong Tao Process to manufacture simvastatin and intermediates
US6002021A (en) * 1998-06-29 1999-12-14 Industrial Technology Research Institute Process for preparing 6(R)-{2-8'(S)-2",2"-dimethylbutyryloxy-2'(S)-6'(R)-dimethyl-1',2',6'7',8' 8'A(R)-hexahydronapthyl-1'(S)-ethyl}-4(R)-hydroxy-3,4,5,6-tetrahydro-2H- pyran-2-one
SI20116A (sl) * 1998-12-02 2000-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nov postopek za pripravo simvastatina in njegovih analogov
US6391583B1 (en) 1998-12-18 2002-05-21 Wisconsin Alumni Research Foundation Method of producing antihypercholesterolemic agents
EP1228057A2 (de) 1999-10-27 2002-08-07 Merck & Co., Inc. Laktonbildungsverfahren
KR20020063174A (ko) * 1999-11-03 2002-08-01 하워드 제이 스미스 앤드 어쏘시에이츠 피티와이 엘티디 간의 선택적 치료방법
US6576775B1 (en) 2000-03-30 2003-06-10 Cheil Jedang Corporation Process for producing simvastatin
CN1446088A (zh) 2000-07-27 2003-10-01 普拉斯化学品有限公司 高度纯化的辛伐他汀组合物
NL1017548C2 (nl) 2001-03-09 2002-09-10 Synthon Bv Een lactonisatie proces.
KR20040026705A (ko) * 2001-08-16 2004-03-31 테바 파마슈티컬 인더스트리즈 리미티드 스타틴의 칼슘 염 형태의 제조 방법
KR100407758B1 (ko) * 2001-08-27 2003-12-01 씨제이 주식회사 스타틴의 제조에 있어서 락톤화 방법
KR100435142B1 (ko) * 2002-01-09 2004-06-09 한미약품 주식회사 개선된 심바스타틴의 제조방법
KR20050098313A (ko) 2003-02-11 2005-10-11 플러스 케미칼스 비.브이. 제어된 범위의 심바스타틴 이량체 함량을 갖는심바스타틴의 제조 방법
TW200510362A (en) * 2003-04-01 2005-03-16 Plus Chemicals Bv Amorphous simvastatin calcium and methods for the preparation thereof
MXPA06004448A (es) * 2003-10-21 2006-07-10 Diversa Corp Metodos para hacer simvastatina e intermediarios.
AU2004323102A1 (en) * 2004-09-08 2006-03-16 Jubilant Organosys Limited An improved process for lactonization in the preparation of statins
CN1754870A (zh) * 2004-09-30 2006-04-05 淮北市辉克药业有限公司 辛伐他汀的制备方法
GB0427491D0 (en) 2004-12-16 2005-01-19 Avecia Ltd Process and compounds
WO2007020079A2 (en) * 2005-08-17 2007-02-22 Synthon B.V. Orally disintegratable simvastatin tablets
US20110059493A1 (en) * 2007-08-27 2011-03-10 Brian Morgan Methods for Making Simvastatin and Intermediates
CN102690254B (zh) * 2008-05-09 2014-06-04 上海医药工业研究院 辛伐他汀铵盐中间体及其制备方法
CN101575286B (zh) * 2008-05-09 2013-06-19 上海医药工业研究院 一种辛伐他汀铵盐的合成方法及所用中间体及其制备方法
ES2343049B1 (es) 2008-10-15 2011-06-10 Neuron Biopharma, S.A. Biosintesis de derivados de monacolina j.
US8470805B2 (en) 2009-04-30 2013-06-25 Kaohsiung Medical University Processes for preparing piperazinium salts of KMUP and use thereof
TWI462739B (zh) 2010-11-02 2014-12-01 Univ Kaohsiung Medical Ｓｉｌｄｅｎａｆｉｌ－同族物四級銨哌嗪鹽類之製備及醫療用途
EP2983711A4 (de) 2013-04-08 2016-11-23 Cytodyn Inc Felinisierte antikörper und verfahren zur behandlung von retrovireninfektionen bei katzen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293496A (en) * 1980-02-04 1981-10-06 Merck & Co., Inc. 6(R)-[2-(8-Hydroxy-2,6-dimethylpolyhydronaphthyl-1)-ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Ｍｂ−５３０ａ誘導体
US4584389A (en) * 1983-10-11 1986-04-22 Merck & Co., Inc. Processes for preparing 6(R)-[2-[8(S)(2,2-dimethylbutyryloxy)-2(S),6(S)-dimethyl-1,2,3,4,4a(S),5,6,7,8,8a(S)-decahydronaphthyl-1(S)]ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one
US4582915A (en) * 1983-10-11 1986-04-15 Merck & Co., Inc. Process for C-methylation of 2-methylbutyrates
JPH0749393B2 (ja) * 1987-06-03 1995-05-31 旭電化工業株式会社 新規化合物及びこれを用いた高脂血症治療薬
US4820850A (en) * 1987-07-10 1989-04-11 Merck & Co., Inc. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
PT88364A (pt) * 1987-09-02 1989-07-31 Merck & Co Inc Process for preparing novel hmg-coa reductase inhibitors
US4866090A (en) * 1988-01-07 1989-09-12 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors

Also Published As

Publication number Publication date
ES2090507T3 (es) 1996-10-16
CA2067722A1 (en) 1992-11-02
IE921399A1 (en) 1992-11-04
IE73439B1 (en) 1997-06-04
GR3021527T3 (en) 1997-01-31
DE69212884T2 (de) 1997-02-27
JPH0764837B2 (ja) 1995-07-12
EP0511867A1 (de) 1992-11-04
DK0511867T3 (da) 1996-09-09
ATE141584T1 (de) 1996-09-15
EP0511867B1 (de) 1996-08-21
US5159104A (en) 1992-10-27
JPH05230052A (ja) 1993-09-07

Similar Documents

Publication Publication Date Title
DE69212884D1 (de) Verfahren zum Herstellen von Simvastatin
HUT63419A (en) Process for producing mercaptoacetamide derivatives of pyrrolo-, pyrido- and oxazinobenzazepine having encephalinase- and angiotensin-converting enzyme-inhibiting activity
DE68913215D1 (de) Verfahren zur Herstellung hydraulischer Dämpfungsspalten.
DE69206862D1 (de) Verfahren zum Herstellen von organischen Carbonaten
DE69407663D1 (de) Verfahren zum Herstellen von Doppelplüschgeweben
DE69229653D1 (de) Verfahren zur Herstellung von Polycarbonaten
DE69233106D1 (de) Verfahren zur Herstellung von Einzelsträndigen "stem-loop" DNS
DE3855208D1 (de) Verfahren zur Herstellung von hochschlagfesten Polycarbonaten
DE69530592D1 (de) Verfahren zur herstellung von (+/-) calanolide a und zwischenprodukte dafür
FI93863B (fi) Menetelmä kestävän teräksen valmistamiseksi
DE69316268D1 (de) Verfahren zum Herstellen von Glasgegenständen
ATE201025T1 (de) Verfahren zur herstellung von cephalosporinen und zwischenprodukte in diesem verfahren
AT365416B (de) Verfahren zum herstellen von margarine des typs "wasser-in-oel"
DE69201380D1 (de) Verfahren zum Herstellen von Rohrglas.
DE3888279D1 (de) Verfahren zum Herstellen von keramischen Hohlkörpern.
DE59209181D1 (de) Verfahren zur Herstellung von Mikrostrukturkörpern
DE69412559D1 (de) Verfahren zur Vergasung von organischen Materien
DE69223475D1 (de) Verfahren zur Herstellung von Polycarbonaten
DE68916760D1 (de) Verfahren zur Herstellung von Gamma-Lactonen.
DE69208290D1 (de) Verfahren zum Herstellen von Formkörpern mittels CVD und daraus hergestellte Formkörper
DE59008624D1 (de) Verfahren zum Herstellen von kaschierten Formteilen.
DE69225560D1 (de) Verfahren zur Herstellung von Lactonen
DE69406395D1 (de) Verfahren zum kontinuierlichen Herstellen von Dimethylcarbonat
ATE132535T1 (de) Verfahren zur diskontinuierlichen herstellung von l-carnitin auf mikrobiologischem weg
ATE8264T1 (de) Verfahren zur herstellung von aclacinomycinen und verwendete mikroorganismen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee